Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × CTLA-4 Antigen × 30 days × Clear all

Sponsor

Conditions

Melanoma 5 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Neoplasm Metastasis 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Lung Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Vulvar Neoplasms 1 Urachal adenocarcinoma 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Seminoma 1 Rectal Neoplasms 1 Rare Diseases 1 Pseudomyxoma Peritonei 1 Pheochromocytoma 1 Perivascular Epithelioid Cell Neoplasms 1 Parathyroid Neoplasms 1 Paranasal Sinus Neoplasms 1 Paraganglioma 1 Paget Disease, Extramammary 1

Interventions

Rituximab 14 CT-P10 6 ibrutinib 5 Magnetic Resonance Spectroscopy 5 Cyclophosphamide 5 zanubrutinib 4 venetoclax 4 pirtobrutinib 4 glofitamab 4 fludarabine 4 Lenalidomide 4 Specimen Handling 3 obinutuzumab 2 fludarabine phosphate 2 acalabrutinib 2 Whole-Body Irradiation 2 Stem Cell Transplantation 2 Cytarabine 2 Cyclosporine 2 Biopsy 2 Bendamustine Hydrochloride 2 voruciclib 1 treosulfan 1 tislelizumab 1 palbociclib 1 ixazomib 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Watchful Waiting 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡